Humane Genomics Analysis: $125K Raised
What is Humane Genomics?
Humane Genomics engineers viruses to create precision therapies that target and eliminate cancer cells.
Founded
2019
Revenue
$1.1-1.6M
Company Stage
Seed
Investors
- Union Square Ventures
YC Batch
S21
Product Features & Capabilities
- RNA-based viral therapies, selective infection and replication, high lytic activity, >1000 on-target to off-target kill ratio, pediatric liver cancer (hepatoblastoma) treatment, in vivo safety data, 50% reduction in tumor volume.
How much Humane Genomics raised
1 - $125,000
September 1, 2021Lead Investor: Y Combinator
Who are the founders of Humane Genomics
PW
Peter Weijmarshausen
Founder
CM
Chad Moles
Founder
